NCT05150431View on ClinicalTrials.gov

Optimized Acute Pain Control With Parecoxib in Uniportal Video-assisted Thoracoscopic Surgery.

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

May 1, 2022

Study Completion Date

May 1, 2022

Conditions
Perioperative CareChronic Post-operative Pain
Interventions
DRUG

Parecoxib

Parecoxib 40mg will be administered to the experimental group if the patient has no contraindication.

DRUG

Placebo

This is normal saline 2ml, which is equal to the volume of parecoxib solution. Placebo will be injected to placebo group 15 minutes before the end of the surgery.

Trial Locations (1)

106

National Taiwan University Cancer Center, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT05150431 - Optimized Acute Pain Control With Parecoxib in Uniportal Video-assisted Thoracoscopic Surgery. | Biotech Hunter | Biotech Hunter